By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Actinium Pharmaceuticals, Inc. 

501 Fifth Avenue

New York City  New York  10017  U.S.A.
Phone: 646-459-4201 Fax: n/a


SEARCH JOBS








Company News
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Presentation At Joseph Gunnar Pioneers 2016 Conference 5/6/2016 12:56:23 PM
Actinium Pharmaceuticals, Inc. (ATNM.OB) To Host Webinar To Discuss SIERRA Trial -- Upcoming Pivotal, Phase 3 Clinical Study For Iomab-B 4/26/2016 9:06:04 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Selection Of Zevacor Pharma, Inc. For Clinical Production And Supply Of Iomab-B For Pivotal Phase 3 SIERRA Trial 4/13/2016 10:08:32 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Further Strengthens Clinical Development Team With Hiring Of Director Of Clinical Operations 4/1/2016 12:20:44 PM
Actinium Pharmaceuticals, Inc. (ATNM.OB) To Present At Sidoti Spring 2016 Emerging Growth Convention 3/24/2016 11:09:02 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) To Present At Cowen and Company 36th Annual Healthcare Conference 2/24/2016 8:53:15 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Release: Strategic Additions In Key Areas Will Support Later Stage Clinical Trials For Iomab-B And Actimab-A 1/27/2016 9:19:33 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) To Present At The 18th Annual BIO CEO & Investor Conference 1/21/2016 8:50:13 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) To Ring First Closing Bell Of 2016 At The New York Stock Exchange 12/28/2015 12:20:30 PM
Actinium Pharmaceuticals, Inc. (ATNM.OB) And Memorial Sloan-Kettering Cancer Center Sign Agreement In Respect Of Certain Liquidity Matters 12/28/2015 12:03:52 PM
12345678910...
//-->